Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study

Bollestad Marianne; Grude Nils; Solhaug Sigrid; Raffelsberger Niclas; Handal Nina; Nilsen Hans-Johnny Schjelderup; Romstad Monica Regine; Emmert Andreas; Tveten Yngvar; Soraas Arne; Jenum Pal A.; Jenum Synne; Moller-Stray Janne; Weme Einar Tollaksen; Lindbaek Morten; Simonsen Gunnar Skov

首页> 外文期刊>The Journal of Antimicrobial Chemotherapy >Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study

【24h】

Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study

机译：ESBL-生产大肠杆菌引起的Pivmecillinam治疗对Pivmecillinam治疗的临床和细菌学疗效：一种预期，多期，观察队列研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: To compare the clinical and bacteriological outcomes of pivmecillinam treatment for community acquired urinary tract infections (UTIs) caused by ESBL-producing Escherichia coli versus non-ESBL-producing E. coli in an outpatient setting.

机译：目的：比较由ESBL-产生的ESCherichia Coli与外部环境中的非ESBL制备大肠杆菌产生的群体获得的尿路感染（UTI）进行临床和细菌结果。

著录项

来源
《The Journal of Antimicrobial Chemotherapy》 |2018年第9期|共7页
作者
Bollestad Marianne; Grude Nils; Solhaug Sigrid; Raffelsberger Niclas; Handal Nina; Nilsen Hans-Johnny Schjelderup; Romstad Monica Regine; Emmert Andreas; Tveten Yngvar; Soraas Arne; Jenum Pal A.; Jenum Synne; Moller-Stray Janne; Weme Einar Tollaksen; Lindbaek Morten; Simonsen Gunnar Skov;
展开▼
作者单位

Univ Oslo Inst Hlth &

Soc Dept Gen Practice Antibiot Ctr Primary Care Oslo Norway;

Univ Oslo Inst Hlth &

Soc Dept Gen Practice Antibiot Ctr Primary Care Oslo Norway;

Univ Hosp North Norway Dept Microbiol &

Infect Control Tromso Norway;

Univ Hosp North Norway Dept Microbiol &

Infect Control Tromso Norway;

Akershus Univ Hosp Dept Microbiol &

Infect Control Lorenskog Norway;

St Olavs Univ Hosp Dept Med Microbiol Trondheim Norway;

Stavanger Univ Hosp Dept Med Microbiol Stavanger Norway;

Unilabs Telelab AS Dept Med Microbiol Skien Norway;

Telemark Hosp Dept Med Biochem Skien Norway;

Vestre Viken Hosp Trust Dept Lab Med Baerum Norway;

Vestre Viken Hosp Trust Dept Lab Med Baerum Norway;

Vestre Viken Hosp Trust Dept Lab Med Baerum Norway;

Vestre Viken Hosp Trust Dept Lab Med Drammen Norway;

Vestre Viken Hosp Trust Dept Lab Med Drammen Norway;

Univ Oslo Inst Hlth &

Soc Dept Gen Practice Antibiot Ctr Primary Care Oslo Norway;

UiT Arctic Univ Norway Univ Hosp North Norway Dept Microbiol &

Infect Control Tromso Norway;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study [J] . Bollestad Marianne, Grude Nils, Solhaug Sigrid, The Journal of Antimicrobial Chemotherapy . 2018,第9期

机译：ESBL-生产大肠杆菌引起的Pivmecillinam治疗对Pivmecillinam治疗的临床和细菌学疗效：一种预期，多期，观察队列研究
2. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli , ESBL-producing or not – a retrospective cohort study [J] . Filip Jans?ker, Jonas Bredtoft Boel, Sara Th?nnings, Infection and Drug Resistance . 2019,第3期

机译：吡维西南与其他抗微生物药相比，社区获得性泌尿道感染（不论是否产生ESBL）的泌尿道感染–一项回顾性队列研究
3. Treatment duration of pivmecillinam in men, non-pregnant and pregnant women for community-acquired urinary tract infections caused by Escherichia coli: a retrospective Danish cohort study [J] . Boel Jonas Bredtoft, Jansaker Filip, Hertz Frederik Boetius, The Journal of Antimicrobial Chemotherapy . 2019,第9期

机译：患有大肠杆菌引起的男性，非孕妇，非孕妇，非孕妇尿路感染的治疗持续时间：回顾性丹麦队列研究
4. Efficacy of antimicrobial impregnated urinary catheter in thwarting foreign body associated urinary tract infections caused by Pseudomonas aeruginosa [C] . Hina Saini, Sanjay Chhibber, Kusum Harjai World biomaterials congress . 2016

机译：抗菌浸渍导尿管对绿脓杆菌引起的异物相关尿路感染的抑制作用
5. The Study of Special Urogynecologic Topics Related to the Pelvic Floor and Lower Urinary Tract: A Focus on Recurrent Urinary Tract Infections Between Two Cohorts of Women & the Assessment of Women's Reluctance to Use Topical Vaginal Estrogen [D] . Dune, Tanaka Junior. 2019

机译：关于盆腔楼层和低尿路相关的特殊辅音学主题研究：对妇女两组队队之间的复发性尿路感染的关注，妇女不愿意使用局部阴道雌激素的评估
6. Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli ESBL-producing or not – a retrospective cohort study [O] . Filip Jansåker, Jonas Bredtoft Boel, Sara Thønnings, 2019

机译：吡维西南与其他抗生素的社区获得性泌尿道感染（不论是否产生ESBL）的泌尿道感染比较–一项回顾性队列研究
7. Clinical and bacteriological effects of pivmecillinam for ESBL-producing Escherichia coli or Klebsiella pneumoniae in urinary tract infections [O] . F. Jansaker, N. Frimodt-Moller, I. Sjogren, 2013

机译：Pivmecillinam在泌尿道感染中ESBL的临床和细菌学作用。尿路感染患有ESBL的大肠杆菌或Klebsiella肺炎

Clinical and bacteriological efficacy of pivmecillinam treatment for uncomplicated urinary tract infections caused by ESBL-producing Escherichia coli: a prospective, multicentre, observational cohort study

摘要

著录项

相似文献

相关主题

期刊订阅